{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:11:37Z","timestamp":1789020697892,"version":"build-2803163510"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>The gangliosidoses are a family of neurodegenerative lysosomal storage diseases that have recently seen promising advances in gene therapy. White matter deficits are well established components of gangliosidosis pathology that are now receiving more attention because they are partially refractory to correction by gene therapy. After a brief synopsis of normal myelinogenesis, this review outlines current viewpoints on the origin of white matter deficits in the gangliosidoses and potential obstacles to treating them effectively by gene therapy. Dysmyelinogenesis (failure of myelin sheaths to form properly) is proposed as the predominant contributor to white matter pathology, but precise mechanistic details are not well understood. The involvement of neuronal storage deficits may extend beyond secondary demyelination (destruction of myelin due to axonal loss) and contribute to dysmyelinogenesis. Preclinical studies in animal models of the gangliosidoses have substantially improved lifespan and quality of life, leading to the initiation of several clinical trials. However, improvement of white matter pathology has lagged behind other metrics and few evidence-based explanations have been proposed to date. Research groups in the field are encouraged to include myelin-specific investigations in future gene therapy work to address this gap in knowledge.<\/jats:p>","DOI":"10.3389\/fncel.2021.682106","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T09:50:30Z","timestamp":1628761830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["White Matter Pathology as a Barrier to Gangliosidosis Gene Therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Anne S.","family":"Maguire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3185-16.2017","article-title":"On myelinated axon plasticity and neuronal circuit formation and function.","volume":"37","author":"Almeida","year":"2017","journal-title":"J. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013468","article-title":"AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.","volume":"5","author":"Baek","year":"2010","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11745-008-3268-0","article-title":"Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease.","volume":"44","author":"Baek","year":"2009","journal-title":"Lipids"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.bbamcr.2014.04.018","article-title":"Temporal oligodendrocyte lineage progression: In vitro models of proliferation, differentiation and myelination.","volume":"1843","author":"Barateiro","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/sj.gt.3302081","article-title":"Widespread distribution of \u03b2-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.","volume":"10","author":"Bourgoin","year":"2003","journal-title":"Gene Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/mt.2013.86","article-title":"Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy.","volume":"21","author":"Bradbury","year":"2013","journal-title":"Mol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","article-title":"Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease.","volume":"263","author":"Bradbury","year":"","journal-title":"Exp. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/humc.2015.002","article-title":"A review of gene therapy in canine and feline models of lysosomal storage disorders.","volume":"26","author":"Bradbury","year":"","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","article-title":"AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease.","volume":"340","author":"Bradbury","year":"2017","journal-title":"Neuroscience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.mt.6300004","article-title":"Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus\u2013mediated gene delivery.","volume":"15","author":"Broekman","year":"2007","journal-title":"Mol. Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/gt.2008.149","article-title":"Mechanisms of distribution of mouse \u03b2-galactosidase in the adult GM1-gangliosidosis brain.","volume":"16","author":"Broekman","year":"2009","journal-title":"Gene Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: Review of clinical, molecular, and therapeutic aspects.","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2009.05947.x","article-title":"Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A.","volume":"109","author":"Buccinn\u00e0","year":"2009","journal-title":"J Neurochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10373","DOI":"10.1073\/pnas.0603765103","article-title":"Effective gene therapy in an authentic model of Tay-Sachs-related diseases.","volume":"103","author":"Cachon-Gonzalez","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/mt.2012.44","article-title":"Gene transfer corrects Acute GM2 gangliosidosis\u2014potential therapeutic contribution of perivascular enzyme flow.","volume":"20","author":"Cach\u00f3n-Gonz\u00e1lez","year":"2012","journal-title":"Mol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/hmg\/ddt459","article-title":"Reversibility of neuropathology in Tay-Sachs-related diseases.","volume":"23","author":"Cach\u00f3n-Gonz\u00e1lez","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1097-4547(19960515)44:4<374::AID-JNR9>3.0.CO;2-9","article-title":"Regulation of brain m calpain Ca2+ sensitivity by mixtures of membrane lipids: activation at intracellular Ca2+ level.","volume":"44","author":"Chakrabarti","year":"1996","journal-title":"J. Neurosci Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00428","article-title":"White matter plasticity keeps the brain in tune: axons conduct while glia wrap.","volume":"12","author":"Chorghay","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"B19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00687809","article-title":"GM 2 gangliosidosis in a Japanese spaniel.","volume":"67","author":"Cummings","year":"1985","journal-title":"Acta Neuropathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00005072-199909000-00001","article-title":"Abnormalities of developing white matter in lysosomal storage diseases.","volume":"58","author":"Folkerth","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s100240050010","article-title":"Infantile G(M1) gangliosidosis: complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination.","volume":"3","author":"Folkerth","year":"2000","journal-title":"Pediatr. Dev. Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymgme.2015.05.003","article-title":"Mucopolysaccharidosis-like phenotype in feline Sandhoff disease and partial correction after AAV gene therapy.","volume":"116","author":"Gray-Edwards","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.omtm.2017.07.005","article-title":"Lipidomic evaluation of feline neurologic disease after AAV gene therapy.","volume":"6","author":"Gray-Edwards","year":"","journal-title":"Mol. Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.omtm.2019.11.023","article-title":"7T MRI predicts amelioration of neurodegeneration in the brain after AAV gene therapy.","volume":"17","author":"Gray-Edwards","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay\u2013Sachs disease.","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ymthe.2017.01.009","article-title":"Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model.","volume":"25","author":"Gray-Edwards","year":"","journal-title":"Mol Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/hmg\/8.5.831","article-title":"Adenoviral gene therapy of the tay-sachs disease in hexosaminidase a-deficient knock-out mice.","volume":"8","author":"Guidotti","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00691417","article-title":"The white matter in GM2 gangliosidosis.","volume":"24","author":"Haberland","year":"1973","journal-title":"Acta Neuropathol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/1759091415568913","article-title":"Myelin abnormalities in the optic and sciatic nerves in mice with GM1-Gangliosidosis.","volume":"7","author":"Heinecke","year":"2015","journal-title":"ASN Neuro"},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0887-8994(92)90361-2","article-title":"Dysmyelinogenesis in animal model of GM1 gangliosidosis.","volume":"8","author":"Kaye","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pneurobio.2016.10.002","article-title":"Emerging therapies for neuropathic lysosomal storage disorders.","volume":"152","author":"Kelly","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/BF00968708","article-title":"Myelination in the developing human brain: Biochemical correlates.","volume":"19","author":"Kinney","year":"1994","journal-title":"Neurochem. Res."},{"key":"B33","first-page":"1219","article-title":"White matter changes associated with feline GM2 gangliosidosis (Sandhoff disease): correlation of MR findings with pathologic and ultrastructural abnormalities.","volume":"16","author":"Kroll","year":"1995","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.molbrainres.2004.10.026","article-title":"\u03b2-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.","volume":"133","author":"Kyrkanides","year":"2005","journal-title":"Mol. Brain Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2007.05.010","article-title":"Intraperitoneal inoculation of Sandhoff mouse neonates with an HIV-1 based lentiviral vector exacerbates the attendant neuroinflammation and disease phenotype.","volume":"188","author":"Kyrkanides","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ymthe.2020.06.021","article-title":"Pronounced therapeutic benefit of a single bidirectional AAV vector administered systemically in Sandhoff mice.","volume":"28","author":"Lahey","year":"2020","journal-title":"Mol Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00234-017-1846-7","article-title":"White matter microstructure damage in tremor-dominant Parkinson\u2019s disease patients.","volume":"59","author":"Luo","year":"2017","journal-title":"Neuroradiology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41434-020-00190-1","article-title":"Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease.","volume":"28","author":"McCurdy","year":"2021","journal-title":"Gene Ther."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007733","article-title":"Sustained normalization of neurological disease after intracranial gene therapy in a feline model.","volume":"6","author":"McCurdy","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/gt.2014.108","article-title":"Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.","volume":"22","author":"McCurdy","year":"2015","journal-title":"Gene Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders.","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0515-3","article-title":"White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes.","volume":"6","author":"Nasrabady","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1177\/0300985810388522","article-title":"Pathology of GM2 gangliosidosis in jacob sheep.","volume":"48","author":"Porter","year":"2011","journal-title":"Vet. Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/gt.2016.62","article-title":"Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.","volume":"23","author":"Powell","year":"2016","journal-title":"Gene Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2015.07.021","article-title":"Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.","volume":"273","author":"Provenzale","year":"2015","journal-title":"Exp. Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/ajmg.a.37468","article-title":"MRI\/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis.","volume":"170","author":"Regier","year":"2016","journal-title":"Am. J. Med. Genet. A."},{"key":"B47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/TACG.S206076","article-title":"GM1 gangliosidosis: mechanisms and management.","volume":"14","author":"Rha","year":"2021","journal-title":"Appl. Clin. Genet."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/1759091415569908","article-title":"AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system.","volume":"7","author":"Rockwell","year":"2015","journal-title":"ASN Neuro"},{"key":"B49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth.","volume":"8","author":"Saher","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ymgme.2012.11.008","article-title":"GM2 gangliosidosis associated with a HEXA missense mutation in Japanese Chin dogs: A potential model for Tay Sachs disease.","volume":"108","author":"Sanders","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations and lipid storage in three variants of tay-sachs disease.","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002943","article-title":"Characterization of inducible models of Tay-Sachs and related disease.","volume":"8","author":"Sargeant","year":"2012","journal-title":"PLoS Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1093\/hmg\/ddr364","article-title":"Adeno-associated virus-mediated expression of -hexosaminidase prevents neuronal loss in the Sandhoff mouse brain.","volume":"20","author":"Sargeant","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ymthe.2019.11.012","article-title":"A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna.","volume":"28","author":"Taghian","year":"2020","journal-title":"Mol. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.gt.3302033","article-title":"Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer.","volume":"10","author":"Takaura","year":"2003","journal-title":"Gene Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/jnen\/63.6.660","article-title":"Perturbed myelination process of premyelinating oligodendrocyte in niemann-picktype C mouse.","volume":"63","author":"Takikita","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid \u03b2-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo.","volume":"3","author":"Tropak","year":"2016","journal-title":"Mol. Ther."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2019.00034","article-title":"Myelin and modeling: bootstrapping cortical microcircuits.","volume":"13","author":"Turner","year":"2019","journal-title":"Front. Neural Circuits"},{"key":"B59","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-004-0848-9","article-title":"The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction.","volume":"107","author":"van der Voorn","year":"2004","journal-title":"Acta Neuropathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of sandhoff disease following intravenous delivery of rAAV9 to mouse neonates.","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","article-title":"Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons.","volume":"10","author":"Walkley","year":"2000","journal-title":"Cereb Cortex"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1093\/hmg\/ddv168","article-title":"Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.","volume":"24","author":"Weismann","year":"2015","journal-title":"Hum. Mol. Genet."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2021.682106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T09:50:36Z","timestamp":1628761836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2021.682106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":62,"alternative-id":["10.3389\/fncel.2021.682106"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2021.682106","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"article-number":"682106"}}